The Committee, therefore, recommended that WHO, in consultation with partners and stakeholders, should develop a proposal for alternative mechanisms to maintain the global and national focus on COVID-19 after the PHEIC is terminated, including if needed a possible Review Committee to advise on the issuance of standing recommendations under the IHR.
The Committee also requested the WHO Secretariat to provide an assessment regarding the regulatory implications for developing and authorising vaccines, diagnostics, and therapeutics if the PHEIC were to be terminated in the coming months.
4913
委员会还鼓励世卫组织进行评估并在必要时加快将COVID-19监测纳入全球流感监测和应对系统。
The Committee also encouraged WHO to assess and, if necessary, to accelerate the integration of COVID-19 surveillance into the Global Influenza Surveillance and Response System.
4914
世卫组织总干事向所有缔约国发出的临时建议
Temporary Recommendations issued by the WHODirector-General to all States Parties
Maintain momentum for COVID-19 vaccination to achieve 100% coverage of high-priority groups guided by the evolving SAGE recommendations on the use of booster doses.
4916
缔约国应计划将COVID-19疫苗接种纳入生命全程的免疫规划中。
States Parties should plan for integration of COVID-19 vaccination into part of life-course immunization programmes.
4917
关于疫苗覆盖率的定期数据收集和报告应包括基础免疫和加强免疫剂次。
Regular data collection and reporting on vaccine coverage should include both primary and booster doses.
4918
（《变化世界中的全球COVID-19疫苗接种战略》：2022年7月更新；
(Global COVID-19 Vaccination Strategy in a Changing World: July 2022 update; Updated WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines January 2023; Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19; Good practice statement on the use of variant-containing COVID-19 vaccines; Behavioural and social drivers of vaccination: tools and practical guidance for achieving high uptake.)
4919
改进向世卫组织报告的SARS-CoV-2监测数据。
Improvereporting of SARS-CoV-2 surveillance data to WHO.
4920
需要更好的数据来：检测、评估和监测新出现的变异株；
Better data are needed to: detect, assess, and monitoremerging variants; identify significant changes to COVID-19 epidemiology; and understand the burden of COVID-19 in all regions.